協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/12/19 | 2,391 | 2,395.5 | 2,353 | 2,379 | -9.5 | -0.4% | 583,100 |
2023/12/18 | 2,385.5 | 2,407 | 2,379.5 | 2,388.5 | -23.5 | -1% | 582,500 |
2023/12/15 | 2,435 | 2,441.5 | 2,397.5 | 2,412 | -32.5 | -1.3% | 1,210,000 |
2023/12/14 | 2,469.5 | 2,471.5 | 2,429 | 2,444.5 | -13 | -0.5% | 689,600 |
2023/12/13 | 2,469.5 | 2,471.5 | 2,450.5 | 2,457.5 | -1 | ±0% | 645,100 |
2023/12/12 | 2,459 | 2,479.5 | 2,442.5 | 2,458.5 | +5.5 | +0.2% | 1,004,500 |
2023/12/11 | 2,414.5 | 2,457 | 2,407.5 | 2,453 | +69 | +2.9% | 1,022,500 |
2023/12/08 | 2,389 | 2,389 | 2,363 | 2,384 | -27 | -1.1% | 1,303,200 |
2023/12/07 | 2,416 | 2,432.5 | 2,395.5 | 2,411 | -27.5 | -1.1% | 822,000 |
2023/12/06 | 2,431.5 | 2,444 | 2,421 | 2,438.5 | +12.5 | +0.5% | 897,400 |
2023/12/05 | 2,408.5 | 2,434.5 | 2,405.5 | 2,426 | +18 | +0.7% | 1,015,300 |
2023/12/04 | 2,400 | 2,408 | 2,377 | 2,408 | -13 | -0.5% | 706,200 |
2023/12/01 | 2,440 | 2,448.5 | 2,411 | 2,421 | -16 | -0.7% | 859,000 |
2023/11/30 | 2,429.5 | 2,438.5 | 2,407 | 2,437 | +5.5 | +0.2% | 1,710,700 |
2023/11/29 | 2,420 | 2,431.5 | 2,410 | 2,431.5 | -9 | -0.4% | 752,000 |
2023/11/28 | 2,400 | 2,445.5 | 2,389.5 | 2,440.5 | +7.5 | +0.3% | 1,107,000 |
2023/11/27 | 2,459 | 2,478 | 2,419 | 2,433 | -17.5 | -0.7% | 754,300 |
2023/11/24 | 2,479.5 | 2,489 | 2,447 | 2,450.5 | -11.5 | -0.5% | 752,500 |
2023/11/22 | 2,467 | 2,484 | 2,456.5 | 2,462 | -1.5 | -0.1% | 515,000 |
2023/11/21 | 2,440.5 | 2,464 | 2,410 | 2,463.5 | +22.5 | +0.9% | 795,700 |
2023/11/20 | 2,431 | 2,457.5 | 2,428.5 | 2,441 | +0.5 | ±0% | 653,900 |
2023/11/17 | 2,407 | 2,441 | 2,402.5 | 2,440.5 | +38 | +1.6% | 613,000 |
2023/11/16 | 2,422.5 | 2,450.5 | 2,393 | 2,402.5 | -61 | -2.5% | 742,800 |
2023/11/15 | 2,436 | 2,467.5 | 2,432.5 | 2,463.5 | +46 | +1.9% | 810,900 |
2023/11/14 | 2,448.5 | 2,448.5 | 2,412 | 2,417.5 | -22.5 | -0.9% | 538,700 |
2023/11/13 | 2,449 | 2,456.5 | 2,429 | 2,440 | -10 | -0.4% | 452,100 |
2023/11/10 | 2,426 | 2,460 | 2,426 | 2,450 | -7.5 | -0.3% | 856,200 |
2023/11/09 | 2,442 | 2,461.5 | 2,440 | 2,457.5 | -13.5 | -0.5% | 847,200 |
2023/11/08 | 2,455 | 2,490.5 | 2,449 | 2,471 | +28.5 | +1.2% | 1,326,200 |
2023/11/07 | 2,443 | 2,466 | 2,430.5 | 2,442.5 | -9 | -0.4% | 1,324,800 |
2023/11/06 | 2,475 | 2,477.5 | 2,442 | 2,451.5 | +47.5 | +2% | 1,550,600 |
2023/11/02 | 2,395 | 2,426.5 | 2,383.5 | 2,404 | -1 | ±0% | 1,832,000 |
2023/11/01 | 2,418.5 | 2,421.5 | 2,373.5 | 2,405 | +47 | +2% | 1,039,500 |
2023/10/31 | 2,321 | 2,373 | 2,315 | 2,358 | +60.5 | +2.6% | 1,039,800 |
2023/10/30 | 2,347 | 2,356.5 | 2,276.5 | 2,297.5 | -99.5 | -4.2% | 1,293,600 |
2023/10/27 | 2,347 | 2,401 | 2,340.5 | 2,397 | +46 | +2% | 671,700 |
2023/10/26 | 2,341 | 2,362 | 2,340 | 2,351 | +1 | ±0% | 794,700 |
2023/10/25 | 2,368 | 2,375.5 | 2,345.5 | 2,350 | +0.5 | ±0% | 886,600 |
2023/10/24 | 2,329 | 2,354 | 2,300.5 | 2,349.5 | -29.5 | -1.2% | 1,754,200 |
2023/10/23 | 2,368 | 2,385.5 | 2,353 | 2,379 | +5 | +0.2% | 794,100 |
2023/10/20 | 2,398 | 2,408 | 2,368 | 2,374 | -28 | -1.2% | 1,177,100 |
2023/10/19 | 2,382 | 2,423 | 2,380 | 2,402 | -46.5 | -1.9% | 1,579,400 |
2023/10/18 | 2,500.5 | 2,505.5 | 2,415.5 | 2,448.5 | -50.5 | -2% | 1,532,000 |
2023/10/17 | 2,481 | 2,526 | 2,479 | 2,499 | +19.5 | +0.8% | 1,070,800 |
2023/10/16 | 2,537.5 | 2,541.5 | 2,475.5 | 2,479.5 | -56.5 | -2.2% | 971,800 |
2023/10/13 | 2,605.5 | 2,608.5 | 2,531 | 2,536 | -86 | -3.3% | 1,003,200 |
2023/10/12 | 2,596.5 | 2,632 | 2,593.5 | 2,622 | +31.5 | +1.2% | 1,158,700 |
2023/10/11 | 2,610 | 2,611.5 | 2,578 | 2,590.5 | -1.5 | -0.1% | 1,071,000 |
2023/10/10 | 2,566 | 2,603 | 2,557 | 2,592 | +25 | +1% | 843,900 |
2023/10/06 | 2,572.5 | 2,596 | 2,562.5 | 2,567 | +23 | +0.9% | 885,100 |
101~
150
件表示中 / 3459件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 259,100円 | +7.0% | -12.6% | 2.24% | 21.92倍 | 1.65倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
塩野義 | 703,500円 | +4.6% | +0.9% | 2.42% | 12.24倍 | 1.61倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 663,900円 | +1.7% | -2.9% | 2.41% | 44.32倍 | 2.18倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 229,000円 | -10.5% | -24.9% | 3.49% | 11.82倍 | 1.36倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 280,500円 | +10.8% | +3.7% | 1.07% | 20.00倍 | 2.60倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
市場注目の銘柄
チャート関連のコラム